Our Services Include:
- A dedicated and professional team of Clinical Research Staff, including; The Director of Research, Principal Investigator, Sub-Investigators, Regulatory Manager, Study Coordinators, Data Managers, Pharmacy Technicians, RN’s, and CT Technicians
- Central IRB
- Gabrail Cancer Center IBC (Institutional Biosaftey Committee)
- Contracting services to produce effective and timely Clinical Trial Agreements
- Advertising department committed to working with sponsors for public relations
- Consistent internal monitoring and mentoring of our research staff
- Planning for long-term research opportunities
- Rapid Recruitment
- Rapid Start Up, 90% of the time we are the first site to open and enroll
- High Patient Retention Rate
- Accuracy and Timely Data Collection
- Free Wireless High Speed Internet
- Access to phone, fax, and copy machine
- Accessible and Free Parking
- Dedicated Monitoring Room for Sponsor Staff
- Electronic Medical Records with secure, read-only access
- Secure climate controlled storage of research records
GCC’s Clinical Research has a strong history of partnering with pharmaceutical companies, contract research organizations, and government agencies to perform Investigator Initiated Research, Bioequivalence studies, Special PK studies, Phase I, Phase II, and Phase III studies.
Phase 1 Clinical Trials at Gabrail Cancer Center
Phase I clinical trials are the most sophisticated and complex initial steps in new drug development. This process involves the first step in testing potential anti-cancer drugs after animal experimentation is completed.
Research centers chosen to conduct Phase I clinical trials in their own designated Phase I unit must demonstrate a plethora of characteristics including utmost accuracy, clinical competency, well-trained dedicated staff, and state-of-the-art facility and equipment necessary to store and reconstitute the experimental agents under strictly-controlled conditions.
This program is destined to accomplish the following noble goals:
- Area patients have now access to these trials in their backyard saving them the inconvenience of traveling a far away distance. Many cancer patients have a limited time to live. It is only right that we make such critical services available to them where they reside and live. We all owe it to our patients to give them access to state-of-the-art, cutting-edge technological advances at their disposal. They deserve that choice. It is up to us, the physicians, to ensure that patients are aware of what is available to them locally.
- Generating new jobs in the area mainly by recruiting fresh graduates from area colleges and universities. We will need additional, qualified workers–our local graduates are a resource.
- Bringing additional revenues from the rest of the U.S. and abroad. These revenues can only create additional high paying jobs for our local, qualified, graduates many of whom leave the region after completing their education.
- Adding Stark County to the Biotech corridor that currently extends from Cleveland to Akron. We, at GCC, are committed and determined to make Canton part of this crucial biotechnology corridor.
Special Equipment and Supplies:
- Refrigerated Centrifuge
- Ambient Centrifuge
- Access to Dry Ice
- Dedicated Research Pharmacy/Secure Storage
- -20 Freezer
- -80 Freezer
- Back-up Generator
- Crash Cart
- Water bath
- Holter Monitor
- Manual and Automated BP monitoring
- ICH-GCP trained
- IATA certified study coordinators
- CLIA certified on-site laboratory
- Imaging (CT scan) center on-site
- In-office pharmacy dispensing
- Private bedrooms
- 24 hour patient monitoring
- 20 Infusion Chairs
- Dedicated Monitoring Space
Our center is located in Belden-Village close to the Akron-Canton airport, shopping, hotels and several dining options available for your business needs.
Gabrail Cancer Center is planning on the development of a dedicated phase 1 healthy volunteer, cancer, and other disease, 20 bed facility at the Higbee Ave location.
For Network opportunities and our SMO visit our website Sargonresearch.com.